IDNAvsSPMD
iShares Genomics Immunology and Healthcare ETF against SPDR Portfolio S&P 400 Mid Cap ETF — the fee, the flows, the book, and a year head-to-head.
Head to head
| IDNA | SPMD | |
|---|---|---|
| Expense ratio | 0.47% | 0.030% |
| Assets | $321M | $18.5B |
| Net flow, 1 month | +$42M | +$303M |
| Net flow, 1 year | +$107M | +$2.4B |
| Return, YTD | +60.4% | +10.8% |
| Return, 1 year | +65.2% | +10.5% |
| Avg daily volume | 192K | 2.2M |
| Holdings | 63 | 401 |
| Listed | Jun 11, 2019 | Nov 8, 2005 |
| Options market | Yes | Yes |
MARKED CELLS LEAD ON THAT LINE · LOWER FEE, LARGER ASSETS, STRONGER FLOWS & RETURNS